RC

Rima Chakrabarti

Biotech investor, operator, and board director

United States

Invests in

Stages:

Locations:

  • Min Investment:

    $700,000.00
  • Max Investment:

    $1,000,000.00
  • Target Investment:

    $850,000.00

Work Experience

2024

  • Co-Founder & Managing Partner

    2024

    Acting CEO of Sentinel Biotherapeutics, a RBL portfolio company

  • Venture Partner

    2024

  • Partner

    2021 - 2024

    Investment portfolio: Remedy Robotics, Dimension Inx, Cypris Materials, Modulus Therapeutics, Faeth Therapeutics, Motif Neuro

  • Principal

    2020 - 2021

  • Adjunct Professor, Bioengineering

    2024

  • Board Member

    2022

  • Board Member

    2021

  • Advisory Board Member

    2023 - 2024

  • Adjunct Professor

    2021 - 2023

    Neuroscience teaching faculty

  • Associate Principal

    2020 - 2020

  • Entrepreneurship Fellow

    2018 - 2020

  • Resident Physician

    2017 - 2018

    Departments of Internal Medicine and Neurology

  • Research Fellow

    2013 - 2017